Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, has partnered with BioLabs as a network-wide sponsor. As part of their sponsorship, Cheisi is sponsoring a competition to award up to two Golden Tickets at a US BioLabs site. Each Golden Ticket provides one year of fully paid individual bench space and membership at Princeton Innovation Center BioLabs (or other BioLabs US sites), a fully-equipped laboratory designed to accelerate early-stage startups working on research and development in the gene editing, mRNA or siRNA field, and/or relevant viral and non-viral delivery technologies, for treating rare hematology, immunology, ophthalmology, dermatology, metabolic or lysosomal storage diseases. 

More information and how to apply, can be found here.

Application deadline: Friday, September 22